{"url":"https://lda.senate.gov/api/v1/filings/3efff6d5-4cb2-447a-a666-992ca98b7640/","filing_uuid":"3efff6d5-4cb2-447a-a666-992ca98b7640","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2024,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/3efff6d5-4cb2-447a-a666-992ca98b7640/print/","filing_document_content_type":"text/html","income":null,"expenses":"850000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Todd Gillenwater","dt_posted":"2024-04-22T10:25:51-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"950 F STREET, NW","registrant_address_2":"SUITE 500","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":24817,"url":"https://lda.senate.gov/api/v1/registrants/24817/","house_registrant_id":31049,"name":"MEDTRONIC, INC.","description":null,"address_1":"950 F STREET, NW","address_2":"SUITE 500","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JESSICA BATTAGLIA","contact_telephone":"+1 202-442-3622","dt_updated":"2026-07-28T14:01:16.219938-04:00"},"client":{"id":132539,"url":"https://lda.senate.gov/api/v1/clients/132539/","client_id":12,"name":"MEDTRONIC INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"TEC","general_issue_code_display":"Telecommunications","description":"Issues related to cybersecurity S. 686, Restricting the Emergence of Security Threats that Risk Information and Communications Technology Act or the RESTRICT Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41412,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"BATTAGLIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Issues related to intellectual property, including S. 2140, the Patent Eligibility Restoration Act of 2023 and S.2220 the Promoting and Respecting Economically Vital American Innovation Leadership Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Issues related to anti-trust and competition","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Issues related to Medicare coverage and payment for breakthrough medical devices, including H.R.1691, Ensuring Patient Access to Critical Breakthrough Products Act Issues related to Medicare coverage of digital health technologies Issues related to Medicare Physician Fee Schedule","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":66189,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":"E","last_name":"GILLENWATER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Issues related to the taxation of multinational corporations","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41412,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"BATTAGLIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63409,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"PISANELLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Issues related to global supply chains Issues related to US-China trade","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":41412,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"BATTAGLIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63409,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"PISANELLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Issues related to disparities of care Issues related to medical device electronic labeling,including H.R. 3723 - Medical Device Electronic Labeling Act Issues related to the sterilization of medical devices Issues related to servicing and repair of medical devices Issues related to FDA device shortage reporting Issues related to FDA third-party review program Issues related to the transport of medical devices with batteries Issues related to artificial intelligence and other advanced software in health care H.R. 5662/S. 2907, the Medical Device Recall Improvement Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":63409,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"PISANELLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66189,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":"E","last_name":"GILLENWATER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"ENV","general_issue_code_display":"Environment/Superfund","description":"Monitoring Environmental, Social and Governance (ESG) issues relating to the health sector Issues related to the sterilization of medical devices, including the Department of the Interior, Environment, and Related Agencies Appropriations Act, 2024 Issues related to the use of polyfluoroalkyl substances, including H.R. 6805 the PFAS Action Act of 2023","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63409,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"PISANELLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":66189,"prefix":null,"prefix_display":null,"first_name":"TODD","nickname":null,"middle_name":"E","last_name":"GILLENWATER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":41412,"prefix":null,"prefix_display":null,"first_name":"JESSICA","nickname":null,"middle_name":null,"last_name":"BATTAGLIA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Issues related to data privacy and data security, including S. 1409 the Kids Online Safety Act and S. 1628, the Children and Teens Online Privacy Protection Act Issues related to artificial intelligence and emerging technologies, including S. 3312 the AI Research, Innovation and Accountability Act of 2023","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":138562,"prefix":"mrs","prefix_display":"MRS.","first_name":"ANDREA","nickname":null,"middle_name":"BECKER","last_name":"LOONEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":63409,"prefix":null,"prefix_display":null,"first_name":"KRISTINA","nickname":null,"middle_name":null,"last_name":"PISANELLI","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}